Skip to Main Content
 

Global Search Box

 
 
 
 

Files

File List


toledo1234749487.pdf (55.68 MB)

ETD Abstract Container

Abstract Header

Determining the Intracellular Localization and Efficacy of Novel Anticancer Agents in Human Breast Cancer Cell Lines Through the Use of Fluorescent Microscopy

Koegle, Eric Richard
http://rave.ohiolink.edu/etdc/view?acc_num=toledo1234749487

Abstract Details

2008, Master of Science in Pharmaceutical Sciences, University of Toledo, Pharmaceutical Science.
Breast cancer is the second most frequently diagnosed cancer and it ranks second among cancer deaths in women. The anthracycline antibiotic doxorubicin, more commonly known as Adriamycin, is a drug widely used in breast cancer chemotherapy. The mechanism of action of this particular drug is still somewhat unclear, although it is thought to interrupt the progression of a known DNA unwinding enzyme, Topoisomerase II. Another drug used in breast cancer is the anthracenedione, Mitoxantrone. This drug is used in the treatment of metastatic breast cancer. Mitoxantrone is also a Topoisomerase II inhibitor. In some cases, patients become resistant to chemotherapies or have malignancies that recur. These recurrences are sometimes due to cells that are resistant to the current chemotherapeutic tactic being applied. These cells that resistant express P-glycoprotein. P-glycoprotein is an ATP-dependent efflux pump that has evolved to remove harmful substances from cells. In the case of chemotherapy failure, it is a good chance that patients exhibit an overproduction of P-glycoprotein in their tumor cells. This leads to a population of cells that has the unique ability to rid itself of drug and express multi-drug resistance.Although these chemotherapeutic agents are effective anticancer drugs their efficacy is limited by drug-induced cardiotoxicity and therapy must be stopped once a patient has received a cumulative dose of 550mg/m2. Researchers have sought other equally effective Topoisomerase II inhibitors that lack the cardiotoxicity. The development of 9-aza-anthrapyrazoles has led to drugs that are not only active against breast cancer, but are non-cardiotoxic. Furthermore, an interesting observation has been made in which compounds containing two terminal tertiary amine side chains, as seen in the compounds BBR3378 and BBR3409, are active in PGP expressing MCF-7 cells. The purpose of this thesis is to determine the potency of these novel cancer drugs and also to determine intracellular drug distribution in cells. The two colorimetric assays that were used during this project were the MTT cell proliferation assay and a trypan blue exclusion assay.
Miles P. Hacker, Ph.D. (Advisor)
Ezdihar A. Hassoun, Ph.D. (Committee Member)
L.M.Viranga Tillekeratne, Ph.D. (Committee Member)
59 p.
Cellular Biology; Oncology; Pharmaceuticals; Pharmacology; Toxicology
Breast Cancer; Topoisomerase II; MCF-7; BBR3378; BBR3409; P-glycoprotein

Recommended Citations

Citations

  • Koegle, E. R. (2008). Determining the Intracellular Localization and Efficacy of Novel Anticancer Agents in Human Breast Cancer Cell Lines Through the Use of Fluorescent Microscopy [Master's thesis, University of Toledo]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1234749487

    APA Style (7th edition)

  • Koegle, Eric. Determining the Intracellular Localization and Efficacy of Novel Anticancer Agents in Human Breast Cancer Cell Lines Through the Use of Fluorescent Microscopy. 2008. University of Toledo, Master's thesis. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=toledo1234749487.

    MLA Style (8th edition)

  • Koegle, Eric. "Determining the Intracellular Localization and Efficacy of Novel Anticancer Agents in Human Breast Cancer Cell Lines Through the Use of Fluorescent Microscopy." Master's thesis, University of Toledo, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1234749487

    Chicago Manual of Style (17th edition)

toledo1234749487
505
© 2008, all rights reserved.
This open access ETD is published by University of Toledo and OhioLINK.